Blue Bell Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $224K | Buy |
552
+250
| +83% | +$101K | 0.04% | 223 |
|
2025
Q1 | $150K | Buy |
302
+33
| +12% | +$16.4K | 0.03% | 254 |
|
2024
Q4 | $140K | Buy |
269
+5
| +2% | +$2.6K | 0.03% | 239 |
|
2024
Q3 | $163K | Buy |
264
+21
| +9% | +$13K | 0.03% | 234 |
|
2024
Q2 | $134K | Buy |
243
+6
| +3% | +$3.32K | 0.03% | 239 |
|
2024
Q1 | $138K | Buy |
237
+2
| +0.9% | +$1.16K | 0.03% | 223 |
|
2023
Q4 | $125K | Buy |
235
+16
| +7% | +$8.49K | 0.03% | 210 |
|
2023
Q3 | $111K | Buy |
219
+12
| +6% | +$6.07K | 0.03% | 187 |
|
2023
Q2 | $108K | Buy |
207
+5
| +2% | +$2.61K | 0.03% | 187 |
|
2023
Q1 | $116K | Hold |
202
| – | – | 0.03% | 162 |
|
2022
Q4 | $111K | Hold |
202
| – | – | 0.04% | 155 |
|
2022
Q3 | $102K | Hold |
202
| – | – | 0.04% | 150 |
|
2022
Q2 | $110K | Hold |
202
| – | – | 0.04% | 148 |
|
2022
Q1 | $119K | Hold |
202
| – | – | 0.03% | 145 |
|
2021
Q4 | $135K | Buy |
+202
| New | +$135K | 0.04% | 133 |
|
2016
Q4 | – | Sell |
-402
| Closed | -$64K | – | 378 |
|
2016
Q3 | $64K | Hold |
402
| – | – | 0.04% | 178 |
|
2016
Q2 | $60K | Hold |
402
| – | – | 0.04% | 189 |
|
2016
Q1 | $57K | Hold |
402
| – | – | 0.04% | 212 |
|
2015
Q4 | $57K | Hold |
402
| – | – | 0.04% | 199 |
|
2015
Q3 | $49K | Hold |
402
| – | – | 0.03% | 218 |
|
2015
Q2 | $52K | Hold |
402
| – | – | 0.03% | 215 |
|
2015
Q1 | $54K | Hold |
402
| – | – | 0.03% | 210 |
|
2014
Q4 | $50K | Hold |
402
| – | – | 0.03% | 226 |
|
2014
Q3 | $49K | Hold |
402
| – | – | 0.03% | 232 |
|
2014
Q2 | $47K | Hold |
402
| – | – | 0.03% | 225 |
|
2014
Q1 | $48K | Hold |
402
| – | – | 0.03% | 191 |
|
2013
Q4 | $45K | Buy |
+402
| New | +$45K | 0.03% | 203 |
|